Previous Article | Next Article 
Journal of Bacteriology, March 2000, p. 1356-1363, Vol. 182, No. 5
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Gene Families Encoding Phase- and Size-Variable
Surface Lipoproteins of Mycoplasma hyorhinis
Christine
Citti,
Robyn
Watson-McKown,
Martina
Droesse,
and
Kim S.
Wise*
Department of Molecular Microbiology and
Immunology, University of Missouri School of Medicine, Columbia,
Missouri 65212
Received 30 August 1999/Accepted 29 November 1999
 |
ABSTRACT |
A prototype family of seven genes encoding the variable surface
lipoproteins (Vlps) of Mycoplasma hyorhinis is
characterized in the pathogenic SK76 strain, using long-range PCR to
amplify and analyze the single chromosomal region containing expressed genes vlpA to -G, each of which is subject to
phase and size variation. Smaller families of vlp genes in
subclones of SK76 or in another strain of M. hyorhinis,
GDL, can be attributed to deletions of specific vlp genes
from the prototype array described here. Two genes, vlpA
and the newly revealed vlpG, contain repeat motifs in their
3' coding regions that differ from the short tandem repeats in other
vlp genes yet retain structural features common to all vlp gene products. SK76 and GDL vlp gene
families are similarly organized and show sequence similarity between
corresponding individual vlp genes. In light of the
extensive potential for diversity within the vlp gene
system, such conservation provides a provisional basis to hypothesize
that vlp genes may exist in specific arrays that endow
selected functions while retaining common structural features required
during phase-variable expression of this set of gene products.
 |
INTRODUCTION |
Several species of the wall-less
eubacteria Mycoplasma spp. contain in their small genomes
sets of related genes encoding alternative surface lipoproteins
(recently reviewed in reference 9). Studies of some
mycoplasma gene families have revealed that these genes are subject to
high-frequency, reversible mutations that generate alternate or
composite expression patterns of corresponding gene products, as well
as structural variation of the products reflecting changes in
intragenic repetitive regions. Whereas specific functions associated
with mycoplasmal systems of surface variation are not clear,
conservation of such multigenic systems per se suggests that these
variable arrays are pivotal elements in the adaptive strategies of
mycoplasmas as chronic infectious pathogens of various host species.
Determining the range of alternative genes in these families, and the
degree and nature of structural variation in the corresponding gene
products, can provide initial insight into possible functions. This
study examines gene families encoding the variable lipoprotein (Vlp)
system of Mycoplasma hyorhinis.
M. hyorhinis chronically infects the swine host, where it
causes rhinitis as well as severe serositis and arthritis (13, 14). This agent has also been recently linked to the occurrence of otitis media (8). An experimental swine model of
arthritis has been developed using the arthritogenic SK76 strain of
M. hyorhinis, a prototype pathogenic strain derived as a
cloned isolate from a diseased site in a natural infection (11,
12, 14). Subclones of SK76 propagated by passage in broth culture
have been used to characterize the rudimentary Vlp system (11, 12,
21). In addition to its natural host, M. hyorhinis
occupies an important artificial niche as one of the most prevalent
mycoplasmal tissue culture contaminants worldwide (7).
Although the origins and initial pathway for transmitting these cell
culture-adapted contaminants are not known, one such isolate, type
strain GDL (1), has been characterized and shown to contain
additional genes of the Vlp family (10, 22).
Genetic mechanisms underlying mycoplasma surface variation were first
elucidated during a study of M. hyorhinis membrane
lipoproteins of strains SK76 and GDL (3, 12, 20, 21), which
contain repertoires of distinct, single-copy genes encoding
surface-exposed Vlps. Reversible, high-frequency mutations govern the
phase-variable expression of each Vlp product (12, 21).
Insertion or deletion of deoxyadenosine residues in a characteristic
promoter region [poly(A) tract] linked to each vlp gene
results in drastically altered transcription of the individual genes
(3, 21). In addition, size variation of Vlp products results
from in-frame insertion or deletion of tandemly repeated intragenic
sequences within the 3' region of individual vlp genes,
thereby contracting or expanding the surface-exposed C-terminal region
of the corresponding Vlp (12, 21). This structural variation
affects the abundance (3) and functional consequences
(2) of Vlps on the mycoplasma surface, but the full
consequences of this variation are yet to be fully understood. The two
independent forms of reversible mutation affect expression and size of
the product from each vlp gene. In a propagating population,
a single organism carrying multiple vlp genes has the
capacity to generate a large number of variants expressing
antigenically distinct vlp gene products, either alone or in
combinatorial mosaics on the cell surface.
The functions of the Vlp system are likely to be complex. Structural
variation in vlp genes of M. hyorhinis was
recently shown to govern susceptibility to growth inhibition by host
antibody (Ab) produced during infection of swine (2).
Nevertheless, this property may represent only one aspect of a system
which might mediate diverse additional surface interactions. Knowing the size and extent of diversity embodied in the combinatorial repertoire of vlp genes, particularly in a known pathogenic
isolate, will be highly informative in this regard. Defining new or
consistent features of the Vlp system, including additional
vlp genes, their comparative organization in families, and
their common structural features, is an essential step in predicting
the functions of the Vlp system in adaptive variation. Comparison of
cloned isolates of M. hyorhinis strains SK76 and GDL showed
that the vlp repertoires in these two strains comprised
three and six vlp genes, respectively (21, 22).
However, evidence raising the possibility of additional vlp
genes in other isolates of strain SK76 has been reported
(22).
A long-range PCR (LR-PCR) procedure capable of amplifying and analyzing
complete clusters of contiguous vlp genes was therefore developed and used to characterize the vlp family in strain
SK76. This report (i) identifies an expanded prototype vlp
gene family in the pathogenic SK76 strain that includes a new
vlp gene with an atypical intragenic repeat structure, (ii)
shows one vlp gene to have a repeat structure subject to
complex spontaneous intragenic variation, and (iii) provides a
mechanistic basis for differences observed in the size of
vlp gene families in cultured organisms through deletions of
vlp genes or gene blocks from a larger prototype vlp family.
 |
MATERIALS AND METHODS |
Bacterial strains, plasmids, and culture conditions.
M.
hyorhinis SK76 was provided by R. F. Ross, Iowa State
University, Ames, as a filter-cloned culture. Isogenic clonal variants derived from M. hyorhinis SK76 and GDL have been previously
described (3, 12, 21) and were propagated at 37°C in
modified Hayflick broth or agar medium (19). Cloning
procedures were performed using the vector pGEM-7Z (Promega
Corporation, Madison, Wis.) or the pT7Blue T-Vector (Novagen, Madison,
Wis.). Competent Escherichia coli DH5
MCR or DH10B (Life
Technologies, Inc., Gaithersburg, Md.) was used as a host to clone
recombinant products and grown at 37°C in Luria-Bertani broth
supplemented with 100 µg of ampicillin per ml for plasmid preparation.
DNA manipulations and sequencing.
Mycoplasma cells were
harvested and subsequently lysed in a buffer containing 1% sodium
dodecyl sulfate (SDS), 45 mM Tris (pH 8.0), and 9 mM EDTA for 10 min at
50°C and then for 10 min at 37°C. Genomic DNA was extracted by
standard methods (15) or by commercial kits as described
below. Agarose gel electrophoresis, restriction endonuclease digestion,
ligation, chemical transformation, and electroporation were performed
as described elsewhere (15). 3'-Digoxigenin-11-ddUTP
(DIG)-labeled oligonucleotides and Southern hybridization were prepared
according to the Genius system user's guide for membrane
hybridization, version 3.0 (Roche Molecular Biochemicals). For the
partial ClaI restriction digestion, 150 ng of the purified
(Qiaex II gel extraction kit; Qiagen, Inc., Valencia, Calif.) LR-PCR
product of SK76[7] was incubated with 1 U of ClaI
(Promega) for 30 or 60 min, and the reaction was stopped by heat
inactivation at 65°C for 20 min.
DNA sequencing was performed at the University of Missouri DNA Core
Facility, using Taq DyeDeoxy termination and a model 373A or
377 automated sequencer (Applied Biosystems Inc., Foster City, Calif.).
Nucleotide sequences were analyzed using the Genetics Computer Group
sequence analysis software package (5), version 9.1. Oligonucleotides used in this study were also synthesized by the
University of Missouri DNA Core Facility, using a model 394 DNA/RNA
synthesizer or model 3948 nucleic acid synthesizer (Applied Biosystems).
Cloning and DNA sequence analysis.
Genomic DNA from M. hyorhinis SK76[7] clonal variant was digested to completion with
XbaI. The resulting fragments were inserted into
XbaI-restricted, dephosphorylated pGEM-7Z vector. The
ligation mixture was used to transform competent E. coli
DH5
cells by electroporation (Life Technologies). Recombinant clones
carrying vlp genes were detected by hybridization on
colonies, using the DIG-labeled oligonucleotide Sig (Table
1). One recombinant plasmid (PT1)
contained a 4.6-kbp XbaI insert. This was subcloned by
additional ClaI restriction and fully sequenced, revealing a
new vlp gene, vlpG, located upstream of the
vlpA gene and downstream of an IS1221 element. To
identify other vlp genes, the LR-PCR product generated from
the SK76[7] genomic template was digested by ClaI, and
fragments were cloned into pGEM-7Z. Internal ClaI fragments
shown in Fig. 1A (SK76[7]), except the
fragment bearing vlpG, were analyzed by this approach.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 1.
Chromosomal organization of the vlp gene
cluster in M. hyorhinis strains SK76 and GDL. (A)
vlp gene families from strain SK76 containing three
(SK76[3]) or seven (SK76[7]) genes and from strain GDL containing
six genes (GDL[6]). The maps shown are not to scale but reflect the
positions and features of all genes. Solid lines show the chromosomal
location of ClaI (C), XbaI (X), and
EcoRI (E) restriction sites within vlp gene
families and the distinct, conserved regions flanking vlp
families at the 5' (stippled) and 3' (open) boundaries. Corresponding
oligonucleotide primers (LR-F and LR-R [Table 1]), used to amplify
vlp gene clusters by LR-PCR, are indicated by opposing open
arrows above the lines. Large open arrows below each line indicate the
location and orientation of ORFs encoding Vlp proteins, and shaded
boxes (P) indicate the locations of conserved promoter regions upstream
of each vlp gene or in one case a distinctive partial
promoter structure downstream of vlpF (*). The positions and
orientations of IS1221 elements (IS) are shown as large open
boxes. The double asterisk indicates a genomic XbaI fragment
from SK76[7] that was cloned and analyzed further (Fig. 2B). The
LR-PCR product generated from SK76[7] genomic DNA template is
indicated by a line below (LR-PCR amplimer). Additional lines represent
nested PCR products generated from the LR-PCR product template by using
primers described in Table 1. Nested products 1 through 6 were
generated with primer sets N1-F-N1-R, N2-F-N2-R, N3-F-N3-R,
N4-F-N4-R, N5-F-N5-R, and N6-F-N6-R, respectively. (B) Ethidium
bromide-stained amplimers were generated as described in Materials and
Methods from genomic DNA template from clonal isolates SK76[3] (lane
1), GDL[6] (lane 2), and SK76[7] (lane 3) and separated by
electrophoresis through 0.9% agarose gels. Sizes of the amplimers,
determined using lambda HindIII markers (lane 4), are
indicated on the left in kilobase pairs. (C) Southern blot analysis of
ClaI restriction fragments from SK76[7] genomic DNA (lane
1) or the LR-PCR product from SK76[7] (lanes 2 through 4). Blots were
hybridized with oligonucleotide probes (Table 1) representing a highly
conserved signal peptide sequence (Sig) located 3' of the
ClaI site in each vlp gene (lanes 1 and 2), the
3' flanking primer sequence LR-R (lane 3), or the 5' flanking sequence,
LR-F (lane 4). Chromosomal ClaI fragments bearing specific
vlp genes are identified to the left of lane 1, based on
hybridization patterns (data not shown) obtained with oligonucleotides
specific for vlpA to -G. The sizes of fragments
are indicated in kilobase pairs. Comigrating 1.7-kbp fragments bearing
vlpD and vlpE, respectively (vlpD/E),
and 1.6-kbp fragments bearing vlpB and vlpG,
respectively (vlpB/G), were not resolved by the gel system
shown. vlpC and vlpC* indicate ClaI
fragments from genomic (7.0-kbp) and LR-PCR (1.5-kbp) DNA,
respectively, bearing the vlpC gene. (D) ClaI
site mapping of the LR-PCR amplimer bearing vlp genes. A
partial ClaI digest of the LR-PCR product from SK76[7] was
subjected to Southern blot analysis with oligonucleotide probes LR-R
(lane 1) and LR-F (lane 2) to identify partially and completely
digested fragments bearing these 3'- and 5'-terminal flanking
sequences, respectively. Sizes of fragments are indicated to the left
of each lane. The terminal 1.5-kbp 3' fragment and 0.8-kbp 5' fragment
correspond to those in the complete digests shown in panel C, lanes 3 and 4. Additional gels resolving larger fragments are not shown. (This
figure was constructed using Adobe Photoshop version 4.0 and 5.0 for
Windows NT, Magicscan V4.1, Umax Power Look III scanner,
Hewlett-Packard LaserJet 4000N printer, and Dell OptiPlex GXPro or
Gateway E-4100 computer.)
|
|
Identification and sequence comparison of vlpA
genes.
To identify and characterize vlpA genes from
assorted clonal isolates, PCR was first used to amplify the
vlpA gene from chromosomal DNA. The amplimers were purified
and sequenced either directly or after cloning into pT7Blue T-Vector.
PCR was performed in a volume of 100 µl with 5 U of AmpliTaq DNA
polymerase (PE Corp., Norwalk, Conn.), 0.3 mM each primer, 0.35 mM
deoxynucleoside triphosphate mix (10 mM each; Life Technologies), 1.75 mM MgCl2, 1× AmpliTaq DNA polymerase buffer II, and 20 ng
of genomic DNA. Thermocycling was performed in a Perkin-Elmer DNA
Thermo Cycler 480 with the following conditions: 1 cycle at 94°C for
2 min; 40 cycles at 94°C for 1 min, 57°C for 1 min, 72°C for 2 min; and a final extension cycle of 72°C for 7 min. Ten microliters
of the PCR product was analyzed on a 0.8% agarose gel (FMC
BioProducts, Rockland, Maine). The resulting PCR products were purified
with a QIAquick gel extraction kit (Qiagen), and 375 fmol was sequenced
directly. In some instances, indicated below, the purified PCR product
was ligated into pT7Blue T-Vector and sequenced using T7 and U19
primers provided by Novagen. Additional internal primers were used to
obtain and confirm sequences.
The vlpA gene of the M. hyorhinis strain GDL[6]
clonal isolate (see Fig. 3B) was amplified from genomic DNA, as
described above, using the forward primer vlpFtip-F
5'-CAAGTCTCAAAATAACAACTATTC-3', located at the 3' end of
vlpF (Fig. 1A), and the reverse primer p9vlpA-R
5'-TAATAGGAACTAAGATGTGTGTTG-3', complementary to the 3' end
of vlpA of GDL[6]. This sequence includes a portion of the
vlpA tip structure, conserved between SK76[3] and
GDL[6]. PCR products containing vlpA were purified and
cloned into pT7Blue T-Vector (Novagen). Sequences obtained directly
from the PCR product and from the cloned insert were identical.
The vlpA genes from spontaneous size variants of SK76[3]
were amplified from genomic DNA extracted using a Wizard genomic DNA
purification kit (Promega). Primers used for amplification were N1-F
(Table 1) and p9vlpA-R. The PCR products were purified and sequenced
directly using these same primers. The vlpA amplimer from
the clonal variant A87 was also cloned into pT7Blue T-Vector to confirm
the sequence. As a result of this analysis, the sequence of the A39
size variant, described in a previous study (21), has been
corrected in the GenBank database (accession no. X62936).
LR-PCR and nested PCR.
LR-PCR and nested PCR products were
produced using the protocol of the Expand Long Template PCR system
(Roche Molecular Biochemicals). The LR-PCR DNA template was generated
using primers LR-F and LR-R (Table 1) from genomic DNA. Nested PCR
products were generated using 20 ng of the LR-PCR product as template
and the nested primer sets listed in Table 1. The annealing
temperatures for the primer sets varied and were typically 6 to 9°C
below the predicted primer melting temperature. Identification of
vlp genes was determined by direct sequencing of
corresponding PCR fragments purified with a Qiaex II or QIAquick gel
extraction kit (Qiagen) or by sequencing subcloned restriction
fragments of the PCR products.
Antibodies to synthetic Vlp peptides and immunoblotting
procedures.
The synthetic peptide pepG was prepared on a model
432A peptide synthesizer (Applied Biosystems) by standard
9-fluorenylmethylcarbonyl protection chemistries and purified as
previously described (4, 22). The amino acid sequence of
pepG, C-SGTSSTTETGSTTESSGQA)DSTSGTSTSI, corresponds to the
C-terminal 29 amino acid residues of VlpG deduced from the 3' region of
the vlpG gene sequence determined in this study. The
parenthesis indicates the end of a 22-residue repeat unit in the VlpG
sequence, and the underlined residues indicate an adjoining partial
repeat comprising part of the tip structure. The Cys residue was
incorporated at the N terminus in order to couple the peptide to
maleimide-activated keyhole limpet hemocyanin, using a hapten carrier
conjugate kit (Pierce Chemical Co., Rockford, Ill.). A BALB/c mouse was
immunized with three weekly intraperitoneal injections of approximately
15 µg of conjugated peptide emulsified with incomplete Freund
adjuvant. The presence of specific anti-pepG polyclonal Abs (PAbs) in
the hyperimmune serum was monitored by Western blot analysis of defined
clonal variants SK76[3] or GDL[6] that lacked the vlpG
gene or of the clonal variant SK76[7] containing the vlpG
gene. A monoclonal Ab (MAb) directed to a synthetic peptide representative of the C-terminal repeat and tip structure of VlpA has
been described elsewhere (2) and was used as a specific probe for the VlpA product.
Western blotting of SDS-polyacrylamide gel electrophoresis
(PAGE)-separated proteins and colony blotting were performed as described elsewhere (12), using PAb to pepG diluted 1:300 or MAb to VlpA (ascites) diluted 1:1,000 as primary Ab, followed by
peroxidase-conjugated goat antiserum to mouse immunoglobulin G for
detection. Abs were diluted in phosphate-buffered saline containing
10% calf serum.
Nucleotide sequence accession numbers.
The following
sequences (with corresponding accession numbers) were deposited in the
GenBank sequence database: PCR-derived sequences of A39 (AF193874), A46
(AF193875), A50 (AF193876), A57 (AF193877), and A87 (AF193878),
IS1221-vlpG-vlpA-IS1221 from SK76[7]
(AF193880), and vlpA from GDL[6] (AF193879).
 |
RESULTS AND DISCUSSION |
LR-PCR strategy to amplify and characterize complete
vlp gene families in the M. hyorhinis
chromosome.
Our previous studies (21, 22) identified
the vlp families in two cloned isolates shown in Fig. 1A.
One clonal isolate from strain SK76 (SK76[3]) contained three genes,
vlpA to -C, whereas a clonal isolate (47.1.2) of
type strain GDL contained six genes, including additional genes
vlpD to -F (Fig. 1, GDL[6]).
In both strains, all vlp genes occurred in single copy, were
clustered as shown in association with IS1221 elements
(23), and were flanked by consistent chromosomal boundary
sequences. Further analysis of early-passage SK76 revealed a
subpopulation that contained more than three vlp genes
(10, 22). The presence of this SK76 variant population was
compatible with the possibility that the original pathogenic strain
(cloned at the time of isolation) contained a more extensive repertoire
of vlp genes that might differ from that in the extensively
passaged GDL strain derived from tissue culture. To analyze the SK76
population containing the expanded repertoire, a variant (termed
SK76[7]; clonal isolate 8II) was selected, and a general method to
more directly characterize the composition and organization of
vlp gene families was developed. This was needed as an
alternative to complement the traditional chromosomal cloning
protocols, which were confounded by redundancy and size variation in
intergenic and intragenic sequences throughout this region.
Based on the premise (confirmed below) that the vlp family
in SK76[7] would be flanked in the chromosome by the distinctive sequences at each boundary of the two known families, we designed primers (shown as opposing arrows in Fig. 1A) and developed conditions for LR-PCR amplification of complete vlp gene clusters from
chromosomal DNA templates derived from mycoplasmal clonal isolates.
Examples of the products obtained with these flanking primers are shown in Fig. 1B. LR-PCR amplimers from the three-gene SK76[3] isolate and
six-gene GDL[6] isolate showed the expected 4.8- and 8.8-kbp sizes,
respectively, as predicted from previous cloning, restriction analysis,
and sequencing of these vlp gene families (21,
22). The authenticity of LR-PCR amplimers from these
vlp gene families was confirmed by diagnostic Southern
hybridization of ClaI and XbaI fragments as
previously described (21, 22). Amplification products were
reproducibly obtained and, based on subsequent sequencing of various
regions and comparison to known vlp gene sequences, appeared
to be free of PCR-derived errors in amplification (data not shown).
The vlp family of the SK76[7] clonal subpopulation was
analyzed using LR-PCR in conjunction with conventional mapping
techniques. First, an LR-PCR amplimer of approximately 14.4 kbp was
obtained (Fig. 1B, lane 3). This was larger than known vlp
families and could reflect highly extended repeat structures in
individual vlp genes, additional IS1221 elements,
additional vlp genes, or unknown sequences. Southern
hybridization with probes specific for each of the known vlp
genes was used to further characterize the LR-PCR amplimers. These
probes represented the distinctive repeat regions of each of the genes
vlpA to -F as described previously (3, 21,
22). Because vlp genes contain a highly conserved DNA
sequence encoding the prolipoprotein signal peptide common to all Vlp
products, and because this sequence contains a distinctive ClaI restriction site accounting for all ClaI
sites in the known vlp gene clusters (Fig. 1A),
ClaI restriction fragments could be used to segregate
individual vlp genes (21, 22). ClaI
fragments bearing vlp genes could be identified by their
hybridization with a conserved signal peptide probe (Sig) immediately
downstream of the ClaI site and further distinguished using
specific probes for individual vlp genes (Table 1).
ClaI restriction of chromosomal DNA from the SK76[7]
isolate, or of the LR-PCR amplimer generated from this isolate, enabled assignment of known vlp genes to ClaI fragments
and a comparison of the genomic organization with that found in the
LR-PCR product. The pattern of ClaI restriction fragments
hybridizing with vlp gene probes was completely concordant
between chromosomal DNA and the LR-PCR product, with the anticipated
exception of a 1.5-kbp ClaI fragment at the 3' end of the
LR-PCR product bearing vlpC. Figure 1C (lanes 1 and 2)
compares these patterns, using the conserved vlp signal
peptide probe to elucidate all ClaI fragments bearing vlp genes. Probes specific to known vlp genes
(and later to a new gene, vlpG, described below) further
assigned specific genes to these fragments and additionally confirmed
that known vlpA to -F gene sequences were present
in SK76[7]. Higher-resolution gels revealed two pairs of nearly
comigrating bands (data not shown), indicated in Fig. 1C as
vlpD/E and vlpB/G. To complete the restriction
analysis of the LR-PCR product, the distal ClaI fragments at
the 5' and 3' ends of the amplimer were identified with probes
representing the chromosomal boundary primers used to generate the
LR-PCR product. The 1.5-kbp 3' ClaI fragment is shown in
lane 3 (this fragment also bears vlpC), and the 0.8-kbp 5'
ClaI fragment is shown in lane 4 (this fragment bears no
target for vlp probes). XbaI fragments of the
LR-PCR amplimer were also subjected to hybridization with
vlp-specific probes, in order to map specific genes onto
these larger fragments. The distribution of individual vlp
genes on ClaI and XbaI fragments is summarized in
Table 2. With the exception of an
unusually large XbaI fragment bearing vlpA, the
pattern was generally comparable to that for the vlp family
previously identified (22) in GDL[6]. As in earlier studies, no evidence for vlp-related sequences outside this
cluster was found in strain SK76[7].
Due to similarity in the sizes of some ClaI fragments
bearing vlp genes, an independent method was used to
determine the ordered positions of ClaI sites in the LR-PCR
product. This was accomplished by partial ClaI restriction
of the amplimer followed by Southern hybridization of the resulting
fragments with the 3' or 5' primers used to generate the LR-PCR
amplimer (Fig. 1D, lanes 1 and 2, respectively). As seen in the
examples shown, the size interval between fragments could be used to
calculate the distance between successive ClaI sites, from
the 3' or 5' end. Results from ClaI site mapping, along with
mapping of vlp genes to limit fragments shown in Table 2,
are consistent with the map shown in Fig. 1A (SK76[7]).
Another independent approach was used to localize specific
vlp genes and determine their order and orientation. This
employed specific primers to generate nested PCR products amplified
from the LR-PCR product as template. Unique sequences in particular vlp genes were used to design forward and reverse primer
pairs that encompass subsets of vlp genes (Table 1). These
were used to generate a nested set of amplimers (Fig. 1A, numbered 1 through 6) that could be positioned on the restriction map shown
(SK76[7]). The specificities of primer sequences and sizes of
discrete nested PCR products confirmed the positions and relative
orientations of most vlp genes in this complex. Finally, to
further confirm the predicted map shown, specific vlp probes
were hybridized to the nested PCR products 1 through 6, in a dot blot
matrix summarized in Table 2. All of these approaches confirmed the map
shown in Fig. 1A for SK76[7]. The one abnormality in SK76[7]
compared to previously reported vlp families was the
presence of an exceptionally large (4.6-kbp) XbaI fragment
bearing vlpA.
Identification and positional analysis of vlpG, a
structurally distinctive and phase-variable vlp gene.
To examine the genomic region adjoining vlpA, chromosomal
DNA from isolate SK76[7] was digested to completion with
XbaI, and a library was generated by ligating these
fragments with XbaI-digested vector pGEM-7Z, as described in
Materials and Methods. This vector also places inserts under the
inducible T7 promoter for overexpression in E. coli. Clones
from this library that hybridized with the Sig probe (Table 1) were
collected, and the insert of one of these (PT1) was subcloned and sequenced.
The sequence of the 4.6-kbp XbaI DNA fragment in PT1
revealed two adjacent open reading frames (ORFs) typical of
vlp gene structures (Fig. 1A and
2A) described previously (17,
20-22). Comparisons with known vlp gene sequences
identified one ORF as vlpA (also confirmed by independent
serologic means; see below). The second ORF was not previously known
and was designated vlpG. As illustrated in Fig. 1A,
vlpG and vlpA are similarly oriented and are
flanked by portions of two IS1221 elements, positioned in
divergent orientations. A vlpG-specific oligonucleotide
probe was synthesized and used to localize vlpG by Southern
hybridization (Fig. 1C; Table 2) to ClaI or XbaI
restriction fragments generated from genomic DNA and the LR-PCR
amplimer from SK76[7]. The orientation of the 4.6-kbp XbaI
fragment within the family was further established. First, specific
nested PCR products from the LR-PCR amplimer template were generated.
As indicated in Fig. 1A, products 3 and 4 were generated using a
reverse primer representing the specific 3' end of vlpA, and
product 1 was generated using a forward primer in a specific portion
(region II) of vlpA. Second, dot hybridization patterns
established the distribution of all seven vlp genes on these
nested PCR products (Table 2). Collectively, these data confirmed the
positions and orientations of vlpG and vlpA.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Structural features and phase-variable expression of the
vlpG gene. (A) Schematic structure of a prototype
vlp gene compared to that of vlpG, which contains
a characteristic promoter with a homopolymeric tract of adenine
residues (polyA) located between the 35 and 10 sequences and a
likely transcription terminator (T) (3, 12, 20). The
predicted VlpG protein is initiated with a GTG start codon, followed by
a highly conserved signal peptide (region I) with a prolipoprotein
signal peptidase recognition site, AISC, characteristic of known Vlp
proteins (20, 22). The mature VlpG protein is encoded by
region II (divergent among Vlps) and region III (composed of a tandemly
repeated sequence, specific for this Vlp). The distal C-terminal
portion of VlpG (Tip) is composed of a partial repeat motif. The amino
acid sequence of the repeated motif (in single-letter code; hatched) in
region III (showing negatively charged residues) and the location of a
sequence used to generate synthetic peptide pepG are indicated below
the schematic structure of vlpG. Additional repeats in
region III (*) are not shown. (B) Expression of Vlp proteins from
recombinant vlpG and vlpA genes. The genomic
XbaI fragment from SK76[7] bearing genes vlpG
and vlpA (** in Fig. 1A) was cloned and expressed in
E. coli under the T7 promoter (16) as previously
described (22), and Western immunoblots of bacterial lysates
(lanes 1 and 2) were stained with PAb to pepG (lane 1) or a combination
of this PAb and a MAb (2) to VlpA (lane 2). Lane 3 represents a Western blot of SK76[7] mycoplasmas run on the same
(8%) gel and immunostained with PAb to pepG. Relative molecular masses
of recombinant VlpA and VlpG were 87 and 82 kDa, respectively. (C)
Phase variation of VlpG. A colony immunoblot of SK76[7] stained with
PAb to pepG is shown, with a sectored colony indicated by the arrow.
(This figure was constructed using Adobe Photoshop version 4.0 and 5.0 for Windows NT, Magicscan V4.1, Umax Power Look III scanner,
Hewlett-Packard LaserJet 4000N printer, and Dell OptiPlex GXPro or
Gateway E-4100 computer.)
|
|
vlpG contained the typical promoter and poly(A) tract
characteristic of vlp genes and a stem-loop structure
(
G =
10.5 kcal) 3' of the translation stop
(3, 20, 21). The VlpG ORF shown in Fig. 2A extends from a
GTG start codon (typical of Vlp proteins) through structural motifs
consistent with Vlp prolipoprotein processing and repeated regions.
Like ORFs encoding other Vlps, VlpG contains no UGA (Trp) codons and is
overlapped on both strands by additional ORFs (17, 20-22).
To directly evaluate the presence and expression features of a putative
vlpG gene translation product, a specific PAb to a synthetic
peptide (pepG) comprising the predicted C-terminal tip and repeat
structure of VlpG was prepared and used to detect the gene product in
two ways. First, as shown in Fig. 2B, T7 induction of the recombinant
PT1 plasmid, containing the XbaI insert bearing vlpG and vlpA, resulted in overexpression in
E. coli of two products identified, respectively, by
antibody to pepG and a previously described MAb to VlpA (2).
The PAb to VlpG recognized a product of similar size in Western blots
of mycoplasmal proteins (Fig. 2B, lane 3) prepared from isolate
SK76[7]. This result confirmed the translation and the reading frame
(defined by the Ab) of the VlpG product. Because the Ab to VlpG was
determined not to immunostain other known Vlp products (A to F), using
an array of variants of SK76[3] and GDL which lack the
vlpG gene (data not shown), it was further used in colony
immunoblotting (18) to determine whether the VlpG product
expressed in SK76[7] was subject to phase variation. As indicated in
Fig. 2C, the marked sectoring of single colonies revealed by Ab to VlpG
was consistent with the notion that this gene product shared with other
Vlps the feature of phase variation. This was very likely due to
mutations in the poly(A) tract of vlpG (Fig. 2A), analogous
to other vlp genes, that would affect transcription
(3). Finally, the accessibility of the VlpG repeat region
III to the Ab directed to pepG was consistent with the predicted
orientations and surface locations of all other known products of
vlp genes (11, 12).
A noteworthy feature of the VlpG structure is the distinctive
(22-residue) length of the tandem protein repeats in region III of the
product (Fig. 2A). Despite this longer unit, compared to 12 or 13 residues for analogous units in VlpA-F (21, 22), VlpG shares
the charge distribution and composition found in repeat units of all
Vlps, representing a net negative charge and high content of Gly, Ser,
and Thr (17, 20, 22). An unusual feature of VlpG, like all
Vlps, is the discordance between the mass of the protein predicted from
the deduced sequence and the predicted migration of the product in
SDS-PAGE. This feature has recently been attributed to properties of
region III repeats in these proteins (6). The entire
sequence of the vlpG gene could not be precisely determined
due to its extensive repetitive region. However, sequence data clearly
revealed 13 full repeats, all of which were identical. This number was
also consistent with the number of repeats determined by probing
fragments generated from a recombinant insert bearing vlpG,
after partial restriction with XmnI, which recognizes a site
in each repeat unit of vlpG (data not shown). Consequently, the calculated mass of the mature VlpG protein from the SK76[7] strain with 13 full repeats was 30.3 kDa, predicting a much faster migration in SDS-PAGE than the 82-kDa relative molecular mass observed
for both the recombinant and authentic mycoplasmal VlpG products shown
in Fig. 2B.
Overall, the vlpG gene found in SK76[7] encodes a unique
repetitive structure within a product otherwise typical of the Vlp family of lipoproteins. Moreover, the seven-gene repertoire in this
isolate is likely to represent the complete vlp gene family in the original pathogenic SK76 strain (11, 12, 22).
VlpA contains a complex repetitive structure.
While VlpB to -G
contain a region III comprised of nearly identical, tandemly repeated
units of 12, 13, or (in VlpG) 22 amino acids, comparative analysis of
vlpA genes from clonal variants of SK76[3], SK76[7], and
GDL[6] available from this or previous studies revealed a more
complex repeat structure. The repeat structure of the shortest known
VlpA variant, A39 from SK76[3] (Fig.
3A), contains all known repeat elements
of region III in the VlpA product. These include a sequence of 39 amino
acids (rep), a version of rep with a deletion of 60 bp, a small repeat
of 13 amino acids, and a conserved distal C-terminal sequence (Tip).
A39 is the smallest of four spontaneous deletion size variants emerging
in broth culture from a clonal population of SK76[3] expressing the
largest known VlpA, A87 (Fig. 3A). The vlpA sequence from
this A87 clonal variant revealed a much more complex repeat structure
in region III, containing composites of the same basic elements
arranged in alternative configurations as shown in Fig. 3A (including,
for example, rep* and rep**). From the A87 variant of SK76[3], three
other spontaneous deletion variants, in addition to A39, have been
obtained by screening for colony opacity variants that were known to be
correlated with altered length of the VlpA products expressed
(12). Sequences from these variants (A46, A50, and A57),
like that of A39, showed a variety of in-frame deletions within the
vlpA gene. These deletions could be explained by the
elimination of various internal repeated elements from the A87
configuration through intragenic deletion mechanisms (Fig. 3A).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 3.
Comparison of vlpA genes among VlpA size
variants. (A) Size variants of vlpA (A39, A46, A50, A57, and
A87, expressing VlpA protein products of 39, 46, 50, 57, and 87 kDa,
respectively, as determined by SDS-PAGE) were derived from a clonal
lineage of spontaneous variants from SK76[3] (12, 21).
Regions I, II, and III are indicated as in Fig. 2. In region III, a
basic repeat unit (rep; underlined) is indicated by an open box. Filled
areas in region III represent a modified repeat comprising a 60-bp
deletion of the rep unit. Hatched boxes represent identical repeated
sequences of 13 amino acids. Larger composite repeated motifs are
indicated as rep* and rep**. Brackets depict tandemly repeated rep**
sequences. The C-terminal sequence (Tip) is indicated in all variants.
Location of the primers used to amplify portions of vlpA
genes encoding the mature lipoprotein regions are represented by arrows
and are described in Materials and Methods. (B) The structure of
vlpA from a previously described (22) cloned
isolate of M. hyorhinis strain GDL is depicted, using
symbols described for panel A to indicate the repeated structure within
region III. (This figure was constructed using Adobe Photoshop version
4.0 and 5.0 for Windows NT, Magicscan V4.1, Umax Power Look III
scanner, Hewlett-Packard LaserJet 4000N printer, and Dell OptiPlex
GXPro or Gateway E-4100 computer.)
|
|
As the vlpA gene of the SK76[7] isolate was sequenced, we
were able to confirm that it too contained the specific A87
configuration. This might be expected since the SK76[7] and SK76[3]
isolates had the same origin prior to culture passage. Finally,
sequencing of vlpA from the long-term tissue culture
passaged GDL strain showed an intermediate size VlpA, with a repeat
structure having the same basic elements but in yet another unique
configuration (Fig. 3B). Interestingly, this structure could also have
been generated in principle by intragenic deletions from a
configuration such as that in SK76 A87. In light of analysis of these
deletion variants and our earlier demonstration that the
vlpA gene is also subject to expansion in length from small
and intermediate forms (21), these results indicate that
vlpA has a more complex and distinctive repeat structure
than other vlp genes and that diverse variants can occur
spontaneously during propagation in culture conditions.
The natural vlp repertoire.
We propose that the
enlarged vlp gene family in the pathogenic SK76 strain,
containing seven distinct vlp genes, may be a prototype of
vlp families in the natural host environment. Simple deletions from this configuration could yield the SK76[3] family, derived from the same clonal stock of SK76 after passage in broth medium, or the six-gene family in the tissue culture contaminant GDL,
isolated on a different continent over an interval spanning several
years (22). Further examination of field and pathogenic isolates should allow us to test the hypothesis that the natural vlp family contains seven functional vlp genes.
Horizontal sampling may also reveal the conservation of the genomic
context of these arrays, as well as the stability of genetic signatures
linked to IS1221 elements within vlp families
(Fig. 1). Finally, such studies will determine whether or not the
entire family resides on a larger element, or can be located at diverse
chromosomal locations.
The range and nature of functions associated with a possibly fixed
array of structurally diverse vlp genes remains an
intriguing enigma. Considering the nearly limitless diversity (17,
20) embodied in the Vlp system (e.g., through intergenic
recombination, frameshift mutations in overlapping reading frames, or
specific composites created by multiple reiterated sequences in region III of vlpA or the extended repeat unit in region III of
vlpG), selection and maintenance of a specific array of Vlp
products will be a critical point to establish, since it would argue
strongly for specific functions associated with each product,
presumably selected in the natural host niche. This study establishes
the hypothesis and tools to address these questions and identifies additional forms of diversity in two Vlp products that may be useful in
understanding Vlp structure and function.
 |
ACKNOWLEDGMENTS |
We thank Mary F. Kim and Jeong Im for preparation and analysis of
key peptide and serologic reagents used in this study and Matthew Mouw
for assistance in chromosomal analyses.
This work was supported in part by USPHS grant AI31656 from the
National Institute of Allergy and Infectious Diseases and by a
University of Missouri
Columbia Molecular Biology Program fellowship
(C.C.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Microbiology and Immunology, University of Missouri School of
Medicine, Columbia, MO 65212. Phone: (573) 882-5644. Fax: (573) 882-4287. E-mail: wisek{at}health.missouri.edu.
Present address: Institute of Bacteriology, Mycology and Hygiene,
University of Veterinary Medicine, A-1210 Vienna, Austria.
 |
REFERENCES |
| 1.
|
Butler, M., and R. H. Leach.
1964.
A mycoplasma which induces acidity and cytopathic effect in tissue culture.
J. Gen. Microbiol.
34:285-294[Medline].
|
| 2.
|
Citti, C.,
M. F. Kim, and K. S. Wise.
1997.
Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies.
Infect. Immun.
65:1773-1785[Abstract].
|
| 3.
|
Citti, C., and K. S. Wise.
1995.
Mycoplasma hyorhinis vlp gene transcription: critical role in phase variation and expression of surface lipoproteins.
Mol. Microbiol.
18:649-660[CrossRef][Medline].
|
| 4.
|
Cleavinger, C. M.,
M. F. Kim,
J. H. Im, and K. S. Wise.
1995.
Identification of mycoplasma membrane proteins by systematic TnphoA mutagenesis of a recombinant library.
Mol. Microbiol.
18:283-293[CrossRef][Medline].
|
| 5.
|
Devereux, J.,
P. Haeberli, and O. Smithies.
1984.
A comprehensive set of sequence analysis programs for the VAX.
Nucleic Acids Res.
12:387-395.
|
| 6.
|
Leigh, S.,
C. Citti,
J. Im, and K. Wise.
1996.
Aberrant structural features and instability of internal sequences in Vlp lipoproteins defined by analysis of recombinant Vlp fusion proteins.
IOM Lett.
4:386-387.
|
| 7.
|
McGarrity, G. J.,
H. Kotani, and G. H. Butler.
1992.
Mycoplasmas and tissue culture cells, p. 445-454.
In
J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C.
|
| 8.
|
Morita, T.,
H. Fukuda,
T. Awakura,
A. Shimada,
T. Umemura,
S. Kazama, and T. Yagihashi.
1995.
Demonstration of Mycoplasma hyorhinis as a possible primary pathogen for porcine otitis media.
Vet. Pathol.
32:107-111[Abstract].
|
| 9.
|
Razin, S.,
D. Yogev, and Y. Naot.
1998.
Molecular biology and pathogenicity of mycoplasmas.
Microbiol. Mol. Biol. Rev.
62:1094-1156[Abstract/Free Full Text].
|
| 10.
|
Rosengarten, R.,
P. M. Theiss,
D. Yogev, and K. S. Wise.
1993.
Antigenic variation in Mycoplasma hyorhinis: increased repertoire of variable lipoproteins expanding surface diversity and structural complexity.
Infect. Immun.
61:2224-2228[Abstract/Free Full Text].
|
| 11.
|
Rosengarten, R., and K. S. Wise.
1990.
Phenotypic switching in mycoplasmas: phase variation of diverse surface lipoproteins.
Science
247:315-318[Abstract/Free Full Text].
|
| 12.
|
Rosengarten, R., and K. S. Wise.
1991.
The Vlp system of Mycoplasma hyorhinis: combinatorial expression of distinct size variant lipoproteins generating high-frequency surface antigenic variation.
J. Bacteriol.
173:4782-4793[Abstract/Free Full Text].
|
| 13.
|
Ross, R. F.
1990.
Mycoplasmal pneumonia of swine, p. 537-543.
In
A. D. Leman, B. E. Straw, W. L. Mengeling, S. D'Allaire, and D. J. Taylor (ed.), Diseases of swine. Iowa State University Press, Ames, Iowa.
|
| 14.
|
Ross, R. F.,
S. E. Dale, and J. R. Duncan.
1973.
Experimentally induced Mycoplasma hyorhinis arthritis in swine: immune response to 26th postinoculation week.
Am. J. Vet. Res.
34:367-372[Medline].
|
| 15.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 16.
|
Tabor, S., and C. C. Richardson.
1985.
A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes.
Proc. Natl. Acad. Sci. USA
82:1074-1078[Abstract/Free Full Text].
|
| 17.
|
Wise, K. S.
1993.
Adaptive surface variation in mycoplasmas.
Trends Microbiol.
1:59-63[CrossRef][Medline].
|
| 18.
|
Wise, K. S.,
M. F. Kim, and R. Watson-McKown.
1995.
Variant membrane proteins, p. 227-241.
In
S. Razin, and J. G. Tully (ed.), Molecular and diagnostic procedures in mycoplasmology. Academic Press, New York, N.Y.
|
| 19.
|
Wise, K. S., and R. K. Watson.
1983.
Mycoplasma hyorhinis GDL surface protein antigen p120 defined by monoclonal antibody.
Infect. Immun.
41:1332-1339[Abstract/Free Full Text].
|
| 20.
|
Wise, K. S.,
D. Yogev, and R. Rosengarten.
1992.
Antigenic variation, p. 473-490.
In
J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C.
|
| 21.
|
Yogev, D.,
R. Rosengarten,
R. Watson-McKown, and K. S. Wise.
1991.
Molecular basis of Mycoplasma surface antigenic variation: a novel set of divergent genes undergo spontaneous mutation of periodic coding regions and 5' regulatory sequences.
EMBO J.
10:4069-4079[Medline].
|
| 22.
|
Yogev, D.,
R. Watson-McKown,
R. Rosengarten,
J. H. Im, and K. S. Wise.
1995.
Increased structural and combinatorial diversity in an extended family of genes encoding Vlp surface proteins of Mycoplasma hyorhinis.
J. Bacteriol.
177:5636-5643[Abstract/Free Full Text].
|
| 23.
|
Zheng, J., and M. A. McIntosh.
1995.
Characterization of IS1221 from Mycoplasma hyorhinis: expression of its putative transposase in Escherichia coli incorporates a ribosomal frameshift mechanism.
Mol. Microbiol.
16:669-685[Medline].
|
Journal of Bacteriology, March 2000, p. 1356-1363, Vol. 182, No. 5
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gaurivaud, P., Persson, A., Grand, D. L., Westberg, J., Solsona, M., Johansson, K.-E., Poumarat, F.
(2004). Variability of a glucose phosphotransferase system permease in Mycoplasma mycoides subsp. mycoides Small Colony. Microbiology
150: 4009-4022
[Abstract]
[Full Text]
-
van der Woude, M. W., Baumler, A. J.
(2004). Phase and Antigenic Variation in Bacteria. Clin. Microbiol. Rev.
17: 581-611
[Abstract]
[Full Text]
-
Horino, A., Sasaki, Y., Sasaki, T., Kenri, T.
(2003). Multiple Promoter Inversions Generate Surface Antigenic Variation in Mycoplasma penetrans. J. Bacteriol.
185: 231-242
[Abstract]
[Full Text]
-
Persson, A., Jacobsson, K., Frykberg, L., Johansson, K.-E., Poumarat, F.
(2002). Variable Surface Protein Vmm of Mycoplasma mycoides subsp. mycoides Small Colony Type. J. Bacteriol.
184: 3712-3722
[Abstract]
[Full Text]
-
Nussbaum, S., Lysnyansky, I., Sachse, K., Levisohn, S., Yogev, D.
(2002). Extended Repertoire of Genes Encoding Variable Surface Lipoproteins in Mycoplasma bovis Strains. Infect. Immun.
70: 2220-2225
[Abstract]
[Full Text]
-
Labandeira-Rey, M., Baker, E. A., Skare, J. T.
(2001). VraA (BBI16) Protein of Borrelia burgdorferi Is a Surface-Exposed Antigen with a Repetitive Motif That Confers Partial Protection against Experimental Lyme Borreliosis. Infect. Immun.
69: 1409-1419
[Abstract]
[Full Text]
-
Lafontaine, E. R., Wagner, N. J., Hansen, E. J.
(2001). Expression of the Moraxella catarrhalis UspA1 Protein Undergoes Phase Variation and Is Regulated at the Transcriptional Level. J. Bacteriol.
183: 1540-1551
[Abstract]
[Full Text]
-
Glew, M. D., Papazisi, L., Poumarat, F., Bergonier, D., Rosengarten, R., Citti, C.
(2000). Characterization of a Multigene Family Undergoing High-Frequency DNA Rearrangements and Coding for Abundant Variable Surface Proteins in Mycoplasma agalactiae. Infect. Immun.
68: 4539-4548
[Abstract]
[Full Text]